Parallel Bio reimagines the drug discovery process by creating a system that charts the map of human biology. The platform is population-scale, perturbable, and fully human, revealing the biological landscape of any disease. It uses groundbreaking biological and computational tools combined with a growing biobank of patient samples to generate proprietary data. The company aims to transform drug discovery and pave the path to a new era of human health.